Suchergebnisse - "Lo, Mimi"

PubPharm (35)

1

Characterization of direct oral anticoagulants use in adult hematopoietic stem cell transplant recipients

enthalten in: Journal of thrombosis and thrombolysis | 2024

von Yang, C. | Khan, F. | MacDonald, C. | +8

2

Access to Financial Assistance Programs and Their Impact on Overall Spending on Oral Anticancer Medications at an Integrated Specialty Pharmacy

enthalten in: JCO oncology practice | 2024

von Ragavan, M. | Swartz, S. | Clark, M. | +4

3

Efficacy and toxicity of midostaurin with idarubicin and cytarabine induction in FLT3-mutated acute myeloid leukemia

enthalten in: Haematologica | 2023

von Lee, J. | Wagner, C. | Prelewicz, S. | +11

4

Evaluation of venous thromboembolism prophylaxis protocol in hematopoietic cell transplant patients

enthalten in: Bone marrow transplantation | 2023

von Lee, A. | Badgley, C. | Lo, M. | +7

5

Impact of corticosteroids on efficacy of BCMA targeted CAR-T therapy in multiple myeloma

enthalten in: Leukemia & lymphoma | 2023

von Duvalyan, E. | Shah, N. | Lo, M. | +6

6

Characterization of direct oral anticoagulants use in adult hematopoietic stem cell transplant recipients

enthalten in: Journal of thrombosis and thrombolysis | 2023

von Yang, C. | Khan, F. | MacDonald, C. | +8

7

Predictors of lenalidomide maintenance duration after autologous stem cell transplant in patients with multiple myeloma

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2023

von Rath, C. | Yoo, C. | Cheplowitz, H. | +14

8

Intensity of Cyclophosphamide-Based Bridging Therapy Before Chimeric Antigen Receptor T Cell Therapy in Myeloma

enthalten in: Transplantation and cellular therapy | 2023

von Zafar, A. | Huang, C. | Lo, M. | +7

9

Safety and Efficacy of BCMA CAR-T Cell Therapy in Older Patients With Multiple Myeloma

enthalten in: Transplantation and cellular therapy | 2023

von Reyes, K. | Huang, C. | Lo, M. | +8

10

Evaluation of pulmonary toxicities in lymphoma patients receiving brentuximab vedotin

enthalten in: Leukemia & lymphoma | 2022

von Guan, T. | Lo, M. | Young, R. | +8